A prescription can be clinically perfect on paper and still fail as care. The patient stands at a counter, hears the price, does the arithmetic on twelve months of it, and leaves with nothing. Nothing about the medicine was wrong. The system around it was.
That gap — between a correct decision and a decision anyone can actually carry out — is where Dhaval Bhanusali keeps pointing. He is a dermatologist whose work extends well past the exam room into formulation, digital health, prescription access and beauty-company development, and the interesting question is not whether he is a good dermatologist. It is what happens when a physician becomes a builder inside the commercial systems around care, with enough leverage to change them rather than merely work within them.
Access treated as a design problem
His practice biography describes professional projects that run past the exam room, and some of that work sits closer to prescription access than to treatment itself — the unglamorous business of making certain compounded dermatologic prescriptions easier and cheaper for a patient to obtain. The economics of any venture built around that will keep shifting. The underlying idea is more durable.
Efficacy on paper does not solve friction at the pharmacy counter, insurance exclusions, or the plain cost of staying on a treatment long enough for it to matter. Access should not lower prescribing standards. It should force the system to solve the administrative and financial mess around good care instead of pretending that mess is a separate problem from the result.
Technology reduces friction and creates conflicts in the same motion
Bhanusali’s work also runs through digital health and product development. When a physician helps build the platform, the recommendation engine or the formula itself, medical expertise moves upstream into system design — genuinely valuable, because clinicians know where patients get stuck in a way a conference room full of product managers usually does not.
The trade-off is conflict visibility. A founder or adviser can have real financial relationships with the systems being discussed. That does not make the work unreliable. It means the audience needs clear disclosure and product-level evidence, not permission to let dermatologist involved quietly become the entire verdict.
Not every friction deserves a platform
Innovation culture assumes every inconvenience deserves an app and every routine needs optimizing into software. Sometimes the better dermatology system is unglamorous: a clear diagnosis, a tolerable generic, a pharmacy the patient can use, and a follow-up plan that does not require downloading anything.
The standard worth applying is not novelty. It is whether the system reduces cost, confusion or delay without quietly weakening the quality of the decision underneath it.
The credentials, and who is vouching for them
Mount Sinai lists Bhanusali as board-certified by the American Board of Dermatology and a Clinical Instructor in Dermatology. His training runs through Michigan State University College of Human Medicine, an internship at Stony Brook, and dermatology residency at Mount Sinai West. Hudson Dermatology and Laser Surgery, his practice, describes his focus as scars, hair loss, laser surgery and innovation — areas where cosmetic outcome, medical diagnosis and device selection overlap fast.
Worth naming, because it is not true of every file like this one: one of the two sources below is an academic institution rather than something he controls. That is a thin but real independent check on the training claims, and I would rather say so than let a practice page stand in for verification.
Formulation gets judged at the formula, not the résumé
Beauty companies increasingly recruit dermatologists during development, which can genuinely improve ingredient selection and claims discipline. It can also produce a halo where the physician’s credentials are asked to prove the finished bottle works — a job credentials were never built to do.
A dermatologist’s involvement tells you something real about the development process. It does not answer what the consumer still needs to know: what the formula is for, whether the finished product itself was tested, how meaningful the result was, and what is already in the cabinet doing the same job for less. Medical involvement is a feature. It was never a substitute for the evidence file. Lara Devgan sits in the same position with a skincare company attached, and the questions do not change.
Devices need exactly the same separation
Device-based aesthetics is particularly vulnerable to authority stacking. Physician, machine, patent language and dramatic before-and-after photography can make a treatment feel more settled than the evidence supports. Keep the layers apart: what exact device, for what indication, what regulatory status applies to that specific use, and how much of the outcome depends on operator skill versus the machine. The more futuristic the device looks, the more useful the boring questions become.
The physician-founder needs a clean audit trail
A clinician can be a strong founder precisely because medical experience surfaces real unsolved problems. The same clinician can profit directly when their solution wins. Neither fact deserves a cynical response. Both require role clarity.
Is this person speaking as the treating dermatologist, the founder, or the paid adviser in this particular sentence? Which claims come from independent evidence and which come from the company? Good disclosure protects trust because it lets the audience see the whole decision instead of asking a credential to quietly cover for a business model.
What his career shows is dermatology treated as more than a sequence of appointments — cost, access, formulation and distribution all change whether care works in real life. The caution runs just as clear. Whenever any physician becomes a builder, the solution owes more transparency, not less, and not because a particular founder has withheld it. Because a medical credential makes it far too easy for everyone to stop asking.
The two pages this rests on
- Mount Sinai: current academic role, dermatology training, board certification, and affiliations
- Hudson Dermatology and Laser Surgery: current practice focus and professional projects
Editorial note: This profile is based on public academic and practice information checked August 8, 2026. It is not medical advice, a personal endorsement, or a claim of treatment or product experience.
Source file